Atlas Trials

BerGenBio ASA

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch BerGenBio ASA

RecordFirmDate
A Clinical Study of Bemcentinib With Standard of Care Chemoimmunotherapy in Untreated Advanced/Metastatic Non-small Cell Lung Cancer Patients With a Mutation in the STK11 Gene (NCT05469178)BerGenBio ASA2023-03-03
A Study to Investigate 14C-bemcentinib in Healthy Male Subjects (NCT06469138)BerGenBio ASA2022-08-02
A Study of Tilvestamab (BGB149) in Relapsed, Platinum-resistant, High-grade Serous Ovarian Cancer (HGSOC) Participants (NCT04893551)BerGenBio ASA2021-02-25
A Study of Bemcentinib for the Treatment of COVID-19 in Hospitalised Patients (NCT04890509)BerGenBio ASA2020-10-20
A First-time-in-human Study of BGB149 (NCT03795142)BerGenBio ASA2018-12-19
Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) (NCT03184571)BerGenBio ASA2017-10-02

Track BerGenBio ASA automatically

Every clearance here is in the API, with alerts when new ones post.